Baidu
map

重磅!全新电子病历分级评价高级别医院名单发布!

2017-09-01 刘中正 HC3i中国数字医疗网

9月1日,2017中华医院信息网络大会召开,2016年度最新电子病历高级别医院名单也同期重磅发布。

9月1日,2017中华医院信息网络大会(CHINC)在北京国家会议中心召开。作为我国医院管理领域有重要影响力的学术活动,2016年度最新电子病历高级别医院名单也同期重磅发布

2010年,受原卫生部医政司委托,国家卫生计生委医院管理研究所成立电子病历试点办公室。七年来,医院研究所起草制订了所有电子病历相关的业务规范与管理性行业标准,如《电子病历基本规范》、《电子病历系统功能规范》、《电子病历系统应用水平分级评价标准》、《电子病历应用管理规范》、《电子病历文件管理规范》(起草中)等文件。其中以《电子病历系统应用水平分级评价标准》为依托开展的“电子病历系统应用水平分级评价”工作最为知名,效果也最为显着。

自2011年始,医院研究所自筹资金开发了数据填报平台,开展全国医院信息化基础能力建设培训与标准内容宣贯,组织全国二级及以上医疗机构开展电子病历系统应用水平分级评价工作。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2006085, encodeId=7b1b20060858c, content=<a href='/topic/show?id=4aa13183655' target=_blank style='color:#2F92EE;'>#分级评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31836, encryptionId=4aa13183655, topicName=分级评价)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqcyT7aQIuoYGGYr889lEiaOVWSfvMQ4d2oxhTMlWzEr6lPmg6pxzCVvPScSZrne4JFSyyPRCOxllQ/132, createdBy=416a2500064, createdName=ms3323097325231039, createdTime=Sun Jun 10 18:50:00 CST 2018, time=2018-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444255, encodeId=fd5c14442557f, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fee5134542, createdName=huagfeg, createdTime=Sun Sep 03 10:50:00 CST 2017, time=2017-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549172, encodeId=1e2015491e2a5, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Sun Sep 03 10:50:00 CST 2017, time=2017-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239875, encodeId=32172398e594, content=学习了.谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Sun Sep 03 01:00:43 CST 2017, time=2017-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239402, encodeId=f91e2394027f, content=学习了受益匪浅., beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Fri Sep 01 20:24:23 CST 2017, time=2017-09-01, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2006085, encodeId=7b1b20060858c, content=<a href='/topic/show?id=4aa13183655' target=_blank style='color:#2F92EE;'>#分级评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31836, encryptionId=4aa13183655, topicName=分级评价)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqcyT7aQIuoYGGYr889lEiaOVWSfvMQ4d2oxhTMlWzEr6lPmg6pxzCVvPScSZrne4JFSyyPRCOxllQ/132, createdBy=416a2500064, createdName=ms3323097325231039, createdTime=Sun Jun 10 18:50:00 CST 2018, time=2018-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444255, encodeId=fd5c14442557f, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fee5134542, createdName=huagfeg, createdTime=Sun Sep 03 10:50:00 CST 2017, time=2017-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549172, encodeId=1e2015491e2a5, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Sun Sep 03 10:50:00 CST 2017, time=2017-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239875, encodeId=32172398e594, content=学习了.谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Sun Sep 03 01:00:43 CST 2017, time=2017-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239402, encodeId=f91e2394027f, content=学习了受益匪浅., beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Fri Sep 01 20:24:23 CST 2017, time=2017-09-01, status=1, ipAttribution=)]
    2017-09-03 huagfeg
  3. [GetPortalCommentsPageByObjectIdResponse(id=2006085, encodeId=7b1b20060858c, content=<a href='/topic/show?id=4aa13183655' target=_blank style='color:#2F92EE;'>#分级评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31836, encryptionId=4aa13183655, topicName=分级评价)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqcyT7aQIuoYGGYr889lEiaOVWSfvMQ4d2oxhTMlWzEr6lPmg6pxzCVvPScSZrne4JFSyyPRCOxllQ/132, createdBy=416a2500064, createdName=ms3323097325231039, createdTime=Sun Jun 10 18:50:00 CST 2018, time=2018-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444255, encodeId=fd5c14442557f, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fee5134542, createdName=huagfeg, createdTime=Sun Sep 03 10:50:00 CST 2017, time=2017-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549172, encodeId=1e2015491e2a5, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Sun Sep 03 10:50:00 CST 2017, time=2017-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239875, encodeId=32172398e594, content=学习了.谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Sun Sep 03 01:00:43 CST 2017, time=2017-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239402, encodeId=f91e2394027f, content=学习了受益匪浅., beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Fri Sep 01 20:24:23 CST 2017, time=2017-09-01, status=1, ipAttribution=)]
    2017-09-03 xxxx1054
  4. [GetPortalCommentsPageByObjectIdResponse(id=2006085, encodeId=7b1b20060858c, content=<a href='/topic/show?id=4aa13183655' target=_blank style='color:#2F92EE;'>#分级评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31836, encryptionId=4aa13183655, topicName=分级评价)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqcyT7aQIuoYGGYr889lEiaOVWSfvMQ4d2oxhTMlWzEr6lPmg6pxzCVvPScSZrne4JFSyyPRCOxllQ/132, createdBy=416a2500064, createdName=ms3323097325231039, createdTime=Sun Jun 10 18:50:00 CST 2018, time=2018-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444255, encodeId=fd5c14442557f, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fee5134542, createdName=huagfeg, createdTime=Sun Sep 03 10:50:00 CST 2017, time=2017-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549172, encodeId=1e2015491e2a5, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Sun Sep 03 10:50:00 CST 2017, time=2017-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239875, encodeId=32172398e594, content=学习了.谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Sun Sep 03 01:00:43 CST 2017, time=2017-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239402, encodeId=f91e2394027f, content=学习了受益匪浅., beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Fri Sep 01 20:24:23 CST 2017, time=2017-09-01, status=1, ipAttribution=)]
    2017-09-03 明天会更好!

    学习了.谢谢分享.

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2006085, encodeId=7b1b20060858c, content=<a href='/topic/show?id=4aa13183655' target=_blank style='color:#2F92EE;'>#分级评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31836, encryptionId=4aa13183655, topicName=分级评价)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqcyT7aQIuoYGGYr889lEiaOVWSfvMQ4d2oxhTMlWzEr6lPmg6pxzCVvPScSZrne4JFSyyPRCOxllQ/132, createdBy=416a2500064, createdName=ms3323097325231039, createdTime=Sun Jun 10 18:50:00 CST 2018, time=2018-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444255, encodeId=fd5c14442557f, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fee5134542, createdName=huagfeg, createdTime=Sun Sep 03 10:50:00 CST 2017, time=2017-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549172, encodeId=1e2015491e2a5, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Sun Sep 03 10:50:00 CST 2017, time=2017-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239875, encodeId=32172398e594, content=学习了.谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Sun Sep 03 01:00:43 CST 2017, time=2017-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=239402, encodeId=f91e2394027f, content=学习了受益匪浅., beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Fri Sep 01 20:24:23 CST 2017, time=2017-09-01, status=1, ipAttribution=)]
    2017-09-01 131****1460

    学习了受益匪浅.

    0

相关资讯

五大维度详解电子病历,其标准化程度是人工智能和医疗大数据落地的基石!

电子病历,健康医疗大数据的基础数据库众所周知,电子病历是由医疗机构以电子化方式创建、保存和使用,重点针对门诊、住院患者(或保健对象)临床诊疗和指导干预信息的数据集成系统。是居民个人在医疗机构历次就诊过程中产生和被记录的完整、详细的临床信息资源。它包括病案首页、病程记录、检查检验结果、医嘱、手术记录、护理记录等等。其中既有结构化信息,也有非结构化的自由文本,还有图形图象等信息,涉及病人信息的采集

江西:医院之间将可共享电子病历

到2020年,江西将建成省、市、县三级全民健康信息平台,完成全省人口信息、电子健康档案和电子病历三大数据库的建设,初步建成健康江西全民健康大数据中心。

医生没时间写电子病历?让“患者写”效果更好

《家庭医疗年刊》(Annals of Family Medicine)发起的一项调查研究显示:病人在电子健康档案中输入自己的求医信息有助于医生了解病人的就医需求。根据这项研究,华盛顿大学医学院和贝斯-以色列迪肯尼斯医疗中心发起了试点研究试图证明其可行性、有效性和可接受性。研究结果显示有79%的病人和74%的医护人员反映医患关系得到改善,同时有73%的病人和82%的医护人员表示希望保持这项动议。20

电子病历大改革 梅奥转移20万病例到Epic系统

梅奥已经正式将20万名患者的医疗记录转移到了Epic的电子病历(EHR)系统中。这也意味着Epic的电子病历系统正式取代了梅奥之前使用的Cerner和GE两家公司的三套系统,完成了系统切换。

电子病历:能否破除手写病历顽疾

病历虽小,但反映的问题不容忽视。“天书病历”不仅危及医者公信力、影响患者对自身病情的判断,还极易引发医患矛盾,甚至引发法律纠纷。

电子病历新规来了,都说了啥?

据国家卫计委消息,为保证医患双方合法权益,4月1日起,我国将施行《电子病历应用管理规范(试行)》,电子病历的书写与存储、使用和封存等均需按相关规定进行。

Baidu
map
Baidu
map
Baidu
map